tiprankstipranks
Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
US Market
Want to see INTS full AI Analyst Report?

Compare Intensity Therapeutics, Inc. (INTS) vs. Competitors

252 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Intensity Therapeutics, Inc.
$4.27
$13.75M
-0.84
-42.27%
2 Buy
0 Hold
0 Sell
Moderate Buy
Cellectar Biosciences
$2.54
$23.72M
-0.54
-49.49%
3 Buy
0 Hold
0 Sell
Strong Buy
PDS Biotechnology
$0.22
$11.98M
-0.32
-83.55%
1 Buy
0 Hold
0 Sell
Moderate Buy
GT Biopharma
$0.29
$12.90M
-0.07
-69.16%
1 Buy
0 Hold
0 Sell
Moderate Buy
Celularity
$0.80
$53.55M
-0.51
-52.28%
Senti Biosciences
$0.39
$11.78M
-0.19
-76.87%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INTS
Intensity Therapeutics, Inc.
4.07
-2.80
-40.80%
CLRB
Cellectar Biosciences
2.46
-2.36
-48.96%
PDSB
PDS Biotechnology
0.20
-1.05
-83.68%
GTBP
GT Biopharma
0.29
-0.61
-67.96%
CELU
Celularity
1.88
-0.67
-26.27%
SNTI
Senti Biosciences
0.34
-1.09
-76.22%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts